Cardiovascular Imaging Registry of Canada (CIROC)

University of Calgary

Status: Enrolling

Conditions: Cardiovascular Diseases

Treatments: Diagnostic Test: Diagnostic testing performed as per routine care

Study type: Observational

Funder types: Other

Identifiers

NCT04367220

REB13-0902

Details and patient eligibility

About

A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.

Full description

The Cardiovascular Imaging Registry of Canada (CIROC) was conceived to provide a common standardized architecture for the collection of clinically reported imaging biomarkers, demographic information, resource utilization and clinical outcomes among patients referred to non-invasive cardiac imaging. The Registry was designed to assess the feasibility of implementing personalized care strategies through automated high quality data collection and patient engagement.

The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are engaged by automated, tablet-based tools to collect informed consent and deploy standardized patient health assessments. Standardized reporting of disease features are captured using bespoke reporting tools. All patients are prospectively followed for a period of 10-years using linkage to administrative health data, inclusive of ICD-coded events, laboratory test results, ECG and vital statistics.

Enrollment: 45,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients referred for hospital-based cardiac imaging services

Exclusion criteria

• Failure or provide informed consent

Trial design

45,000 participants in 1 patient group

Patients with known or suspected cardiovascular disease

Description:

All patients with known or suspected cardiovascular disease are studied with a-priori stratification of specific disease-based cohorts.

Treatment:

Diagnostic Test: Diagnostic testing performed as per routine care